Create Account | Forget Password?               
Home Asthma Cancer Cardiology Diabetes Neurology Nutrition Pediatrics OB / GYN General
Health Center
Ads & Resources
Comprehensive Health Directory
Manage Patient Records
 
Home » Cancer
 Cancer Videos  « Go Back

Global Anti-CD20 Monoclonal Antibodies Market to Reach US$12 Billion by 2015, According to New Report by Global Industry Analysts, Inc.

Posted By: Anonymous | Posted On: Jul 07,2010 23:00 pm | View: 11 GIA announces the release of a comprehensive global report on Anti-CD20 Monoclonal Antibodies market. The global market for Anti-CD20 monoclonal antibodies is projected to exceed US$12 billion by the year 2015. Rising incidence and prevalence of autoimmune diseases and hematological malignancies, the major targeted indications of CD20 mAbs, and the existence of high unmet medical needs, are the factors driving growth in the market. Read More: http://www.prweb.com/releases/monoclonal_antibodies/CD20_antibodies/prweb4223914.htm



 
Other Health Sources
About Us |  Contact Us |  Asthma |  Cancer |  Cardiology |  Diabetes |  Neurology |  Diet & Nutrition |  Pediatrics |  OB/GYN |  General
Copyright © 2008-2012, DoctorsOutlook.com, All Rights Reserved.
Disclaimer: Issuers of the submissions/postings are solely responsible for the content of their submissions. Doctorsoutlook.com can't be held liable for the contents of these submissions. In case any submission damages your benefits or violate your rights in any way, please contact us and we'll remove it immediately.